Gilead Sciences reported $13.9B in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US USD 784.94M 85.07M
ALKERMES ALKS:US USD 1.05B 7.81M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 219.21M
Amgen AMGN:US USD 24.06B 4.74B
Biogen BIIB:US USD 9.77B 24.9M
Biomarin Pharmaceutical BMRN:US USD 2.68B 165.1M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Coherus Biosciences CHRS:US USD 448.28M 1.49M
Eli Lilly And LLY:US USD 17.64B 524.7M
Gilead Sciences GILD:US USD 13.9B 723M
GlaxoSmithKline GSK:LN GBP 20.25B 33.94B
Glaxosmithkline GSK:US GBP 20.25B 33.94B
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
Moderna Inc MRNA:US USD 14.3B 734M
Neurocrine Biosciences NBIX:US USD 1.21B 186.2M
Novartis NOVN:VX USD 36.95B 1.19B
Ptc Therapeutics PTCT:US USD 517.26M 177.41M
Puma Biotechnology PBYI:US USD 122.35M 8.07M
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M
Sangamo Biosciences SGMO:US USD 336.62M 6.5M
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Teva Pharmaceutical Industries TEVA:US USD 11.45B 711M
United Therapeutics UTHR:US USD 3.06B 372.1M
Vertex Pharmaceuticals VRTX:US USD 12.27B 767.5M
YTE INCY:US USD 3.82B 195.27M